Viewing Study NCT04556669


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:49 PM
Study NCT ID: NCT04556669
Status: UNKNOWN
Last Update Posted: 2021-05-27
First Post: 2020-09-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors
Sponsor: Hebei Senlang Biotechnology Inc., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module